Error: Could not add to watchlist. X

Oncolytics Biotech Inc

+ Watchlist
ONCY:US
NASDAQ CM
0.580
USD
0.050
9.37%
As of 20:10:00 ET on 08/28/2015.
Open
0.539
Day Range
0.539 - 0.585
Volume
277,228
Previous Close
0.530
52Wk Range
0.400 - 1.422
1 Yr Return
-57.97%
Open
0.539
Day Range
0.539 - 0.585
Volume
277,228
Previous Close
0.530
52Wk Range
0.400 - 1.422
1 Yr Return
-57.97%
YTD Return
9.43%
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (m USD)
68.272
Shares Outstanding (m)
117.710
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Oncolytics Biotech Inc. discovers and develops pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics. The Company is focusing on the development of the reovirus known as REOLYSIN as a potential cancer therapeutic.
ADDRESS
Suite 210
1167 Kensington Crescent NW
Calgary, AB T2N 1X7
Canada
PHONE
1-403-670-7377
  • Bradley G Thompson "Brad"
    Chairman/President/CEO
  • Kirk Look
    Chief Financial Officer
  • Matthew C Coffey "Matt"
    COO/Co-Founder
  • Alan J Tuchman
    Senior VP:Clinical/Chief Medical Ofcr
  • George M Gill
    Senior VP:Regulatory Affairs
Show More